Literature DB >> 16602412

Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.

A Y Coban1, C C Cihan, K Bilgin, M Uzun, A Akgunes, E Cetinkaya, B Durupinar.   

Abstract

OBJECTIVE: To evaluate the performance of blood agar for the susceptibility testing of 50 Mycobacterium tuberculosis clinical isolates against isoniazid (INH), rifampicin (RMP), streptomycin (SM) and ethambutol (EMB).
DESIGN: The activity of the drugs was determined by the proportion method on blood agar instead of Middlebrook 7H10 agar according to Clinical Laboratory Standard Institute recommendations. The final concentrations of INH, RMP, SM and EMB were 0.2 microg/ml, 1 microg/ ml, 2 microg/ml and 5 microg/ml, respectively.
RESULTS: The results were compared with the radiometric proportion method as the reference, and the agreements were determined as 100% for INH and RMP, 92% for SM and 96% for EMB. The specificity, sensitivity, positive predictive value and negative predictive value were 90.4% and 97.5%, 100% and 90%, 66.6% and 90% and 100% and 97.5% for SM and EMB, respectively, while these values were 100% for INH and RMP. The results of susceptibility testing were obtained on the 14th day of incubation.
CONCLUSION: According to this preliminary study, our results suggest that blood agar can be used as an alternative medium for the susceptibility testing of M. tuberculosis strains against INH, RMP, SM and EMB in resource-limited countries. However, further studies are needed before implementating the method in diagnostic laboratories.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16602412

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.

Authors:  Dilek Satana; Ahmet Yilmaz Coban; Meltem Uzun
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

2.  Rapid direct testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin on nutrient and blood agar in resource-starved settings.

Authors:  Luqman Satti; Aamer Ikram; Ahmet Yilmaz Coban; Anandi Martin
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

3.  Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar.

Authors:  Ahmet Yilmaz Coban; Kemal Bilgin; Meltem Uzun; Alper Akgunes; Anne Yusof; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

4.  Evaluation of agar-based medium with sheep sera for testing of drug susceptibility of Mycobacterium tuberculosis to Isoniazid, Rifampin, Ethambutol, and Streptomycin.

Authors:  Ahmet Yilmaz Coban; Meltem Uzun; Bulent Bozdogan
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

5.  Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.

Authors:  Ahmet Yilmaz Coban
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

6.  Cost-effectiveness of blood agar for isolation of mycobacteria.

Authors:  Michel Drancourt; Didier Raoult
Journal:  PLoS Negl Trop Dis       Date:  2007-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.